Universal (UVV) Q4 2024 earnings summary

Executive summary

• FY2024 closed strongly, with tobacco benefiting from favorable mix, strong demand and larger African crops; ingredients advanced its expansion and commercial capabilities.

• FY2024 revenue rose 7% to $2,748.6m; reported operating income increased 23% to $222.0m, while adjusted diluted EPS rose 35% to $5.08.

Financial highlights

• FY2024 gross profit margin was 19.50%, up 167 bps YoY; cost of goods sold increased 5% to $2,212.5m, largely due to higher green tobacco costs.

• FY2024 net income attributable to Universal was $119.6m, or $4.78 diluted EPS, versus $124.1m and $4.97; adjusted net income was $127.1m versus $94.1m.

• Q4 revenue increased 11% to $770.9m; reported operating income was $68.2m versus $52.4m, and adjusted operating income was $73.0m versus $52.4m.

• Q4 net income attributable to Universal was $40.3m, or $1.61 diluted EPS, versus $53.7m and $2.15; adjusted diluted EPS was $1.79 versus $0.97.

Outlook and guidance

• Lancaster’s ingredients expansion is progressing as expected, with full operations anticipated in H2 FY2025 and a meaningful contribution to Ingredients Operations results expected in FY2026.

• New-product sales are expected to increase and contribute to future ingredients earnings; the strategy prioritizes tobacco opportunities while growing ingredients.

• Leaf supply and demand are expected to rebalance over time; most working-capital impact from accelerated Brazil buying is expected to unwind naturally over the next two years.